- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.10. | Flurotech Ltd (2): Flurotech decides helicopter amalgamation won't fly | 3 | Stockwatch | ||
| 07.10. | FluroTech Ltd. Announces Termination of Definitive Agreement with Great Slave Helicopters 2018 Ltd. | 183 | Newsfile | Calgary, Alberta--(Newsfile Corp. - October 7, 2024) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") announces that the amalgamation agreement between the Company and Great Slave Helicopters... ► Artikel lesen | |
| 27.05. | Flurotech Ltd (2): Test | 1 | Stockwatch | ||
| 01.05. | FluroTech Ltd.: FluroTech, to be renamed Consolidated Aerospace Finance Corporation, Announces $22 Million Equity Financing | 216 | GlobeNewswire (Europe) | THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, May 01, 2024 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST.H) ("FluroTech")... ► Artikel lesen | |
| 30.04. | FluroTech Ltd.: FluroTech Announces Debt Settlement Agreement | 475 | Newsfile | Calgary, Alberta--(Newsfile Corp. - April 30, 2024) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce that it has entered into a debt settlement agreement (the "Debt... ► Artikel lesen | |
| FLUROTECH Aktie jetzt für 0€ handeln | |||||
| 26.04. | FluroTech Ltd.: FluroTech Announces Closing of Oversubscribed Private Placement Financing | 715 | Newsfile | Calgary, Alberta--(Newsfile Corp. - April 26, 2024) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce, further to its news release dated April 19, 2024, that it... ► Artikel lesen | |
| 20.04. | FluroTech Ltd.: FluroTech and GS Heli Announce Execution of Definitive Agreement | 1.807 | Newsfile | Calgary, Alberta--(Newsfile Corp. - April 19, 2024) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company"), to be renamed Consolidated Aerospace Finance Corporation ("CAFC") pursuant to the... ► Artikel lesen | |
| 12.03. | FluroTech Ltd.: FluroTech Enters into a Non-Binding Letter of Intent for Change of Business Transaction | 552 | Newsfile | Calgary, Alberta--(Newsfile Corp. - March 11, 2024) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") and Great Slave Helicopters 2018 Ltd. ("GS Heli") are pleased to announce that further... ► Artikel lesen | |
| 21.12.23 | FluroTech Ltd.: FluroTech Enters into Non-Binding Letter of Intent for Reverse Take-Over Transaction and Officer and Board Appointment | 663 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 21, 2023) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") and Great Slave Helicopters 2018 Ltd. ("GS Heli") are pleased to announce that... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADMA BIOLOGICS | 21,370 | 0,00 % | Adma Biologics Aktie: Erholung nach starkem Kursrückgang | ||
| RECURSION PHARMACEUTICALS | 6,040 | 0,00 % | Recursion Pharmaceuticals, Inc.: Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery | Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform will... ► Artikel lesen | |
| EVOTEC | 9,840 | -0,66 % | KURSEXPLOSION bei Biotech-Aktie! BioNTech, Evotec, Nyxoah | Geht es bei Evotec jetzt doch ganz schnell? Ein Finanzinvestor positioniert sich jedenfalls für eine Übernahme und die Aktie schoss zuletzt kräftig nach oben. Ist damit die Enttäuschung über die Quartalszahlen... ► Artikel lesen | |
| QIAGEN | 40,180 | +3,45 % | Neue 6,00% Aktienanleihe mit Barriere auf QIAGEN in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC7RDU1/ WKN VC7RDU) mit Barriere auf die Aktie von QIAGEN (ISIN... ► Artikel lesen | |
| QUANTUM-SI | 1,400 | 0,00 % | Quantum-Si Inc - 8-K, Current Report | ||
| 89BIO | 7,980 | 0,00 % | 89bio, Inc.: 89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting 2024 | SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for... ► Artikel lesen | |
| LONGBOARD PHARMACEUTICALS | 59,76 | 0,00 % | Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological... ► Artikel lesen | |
| RELAY THERAPEUTICS | 4,660 | 0,00 % | Aktie von Relay Therapeutics erreicht 52-Wochen-Tief bei 5,59 US-Dollar | ||
| STRUCTURE THERAPEUTICS | 32,710 | 0,00 % | Structure Therapeutics reports Q3 results | ||
| SPRINGWORKS THERAPEUTICS | 37,440 | 0,00 % | SpringWorks started at outperform by Evercore ahead of FDA decision | ||
| 4D MOLECULAR THERAPEUTICS | 8,410 | 0,00 % | Analyst Expectations For 4D Molecular Therapeutics' Future | ||
| DYNE THERAPEUTICS | 30,000 | 0,00 % | Wissenschaftliche Leiterin von Dyne Therapeutics verkauft Aktien im Wert von 80.539 US-Dollar | ||
| CULLINAN THERAPEUTICS | 12,580 | 0,00 % | Cullinan Therapeutics, Inc.: Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024 | Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune diseases Cullinan will share details of global Phase... ► Artikel lesen | |
| VIR BIOTECHNOLOGY | 6,740 | 0,00 % | Needham & Company LLC Reaffirms Buy Rating for Vir Biotechnology (NASDAQ:VIR) | ||
| VERVE THERAPEUTICS | 4,550 | 0,00 % | Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on October 31, 2024... ► Artikel lesen |
FLUROTECH LTD gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FLUROTECH LTD finden Sie auf Wallstreet Online.
